Table A7.
Primary drug resistance population under different measures.
| Years | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Measures | ||||||
| Baseline parameter (95% CI) | 209 | 235 | 262 | 292 | 323 | |
| (188, 230) | (209, 261) | (231, 294) | (253, 331) | (276, 371) | ||
| (1) The treatment rate is increased by 10% (95% CI) | 208 | 234 | 261 | 291 | 321 | |
| (187, 229) | (209, 260) | (231, 295) | (255, 333) | (277, 374) | ||
| (2) The treatment rate is increased by 20% (95% CI) | 201 | 228 | 257 | 287 | 318 | |
| (181, 222) | (204, 255) | (227, 189) | (251, 327) | (274, 368) | ||
| (3) The withdrawal rate is reduced by 10% (95% CI) | 206 | 231 | 258 | 287 | 318 | |
| (185, 227) | (207, 258) | (229, 291) | (251, 327) | (274, 367) | ||
| (4) The withdrawal rate is reduced by 20% (95% CI) | 202 | 228 | 254 | 283 | 313 | |
| (183, 224) | (205, 255) | (226, 288) | (249, 325) | (272, 365) | ||
| (5) The number of sexual partners is reduced by 10% (95% CI) | 184 | 205 | 227 | 250 | 273 | |
| (168, 199) | (183, 228) | (201, 256) | (218, 284) | (236, 315) | ||
| (6) The number of sexual partners is reduced by 20% (95% CI) | 155 | 172 | 188 | 205 | 221 | |
| (139, 172) | (153, 192) | (166, 212) | (179, 232) | (190, 254) | ||
| (1)(3)(5) combination (95% CI) | 176 | 197 | 219 | 241 | 264 | |
| (157, 194) | (175, 219) | (192, 246) | (209, 275) | (226, 305) | ||
| (2)(4)(6) combination (95% CI) | 154 | 170 | 184 | 201 | 219 | |
| (137, 174) | (151, 190) | (164, 210) | (178, 234) | (189, 250) | ||